Log In
Print
BCIQ
Print
Print this Print this
 

EP-100

Also known as: formerly EP100

  Manage Alerts
Collapse Summary General Information
Company Esperance Pharmaceuticals Inc.
DescriptionFusion protein consisting of a luteinizing hormone-releasing hormone (LHRH) ligand conjugated to a membrane-disrupting peptide
Molecular Target Luteinizing hormone-releasing hormone (LHRH)
Mechanism of ActionCell membrane integrity disruption
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today